Cardiology News

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, today announced the commercial launch of Mosaic Reporting™, a new class of AI-native radiology reporting solution available as part of MosaicOS™. Mosaic Reporting is already deployed to thousands of radiologists through Radiology Partners-affiliated practices, giving Mosaic a scaled real-world environment to refine and expand the platform. Powered by foundation models developed by...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc. (ASX: EBR), developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has initiated a National Coverage Determination (NCD) to evaluate uniform Medicare coverage for leadless LV endocardial pacing used in cardiac resynchronization therapy (CRT). The initiation of the NCD process is a key outcome of EBR’s engageme...

SAN MATEO, Calif. & DALLAS--(BUSINESS WIRE)--Curve Biosciences Unveils Scientific Advisory Board Guiding the Advancement of Whole-Body Intelligence for Chronic Disease...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Proxim Diagnostics Corp., an innovative company developing a handheld, point-of-care immunodiagnostic platform, announced that it has achieved a final development milestone for its Profile platform, including completion of the handheld reader, disposable cartridge, and initial manufacturing capacity. This milestone marks the transition of Proxim’s platform from its product development phase into production readiness for future clinical and strategic partner...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardia...

NEWARK, Calif.--(BUSINESS WIRE)--Corsair Pharma: Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the appointment of Ludwig Hantson, Ph.D., an accomplished global biopharmaceutical leader, to the Ionis Board of Directors, effective immediately.“We are pleased to welcome Dr. Hantson to the board,” said Joseph Loscalzo, M.D., Ph.D., chairman of the Ionis Board of Directors. “Ludwig’s biopharma executive leadership experience will be especially meaningful as Ionis prepares for a steady cadence of new c...

PORTO, Portugal--(BUSINESS WIRE)--Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditions are among the leading causes of death. Following...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Tempus Founder and CEO Eric Lefkofsky will participate in a fireside chat at 2:00 p.m. ET on Monday, June 8. A live webcast of the conversation will be available here. About Tempus Tempus is a technology company advancing precision medicine through the practi...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the appointment of Anne Liddy as Chief Legal Officer, effective August 31. Liddy will oversee the Company’s global legal and compliance function and serve as a member of the Executive Leadership Team. Liddy brings more than two decades of experience advising global healthcare and life sciences companies on complex legal, regulatory, M&A, and compliance matters. She joins LivaNo...